You are here

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer

Authors

  • Yang Zhang State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Fan Huo State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Qiang Cao Department of Urology, the First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Ru Jia State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Qiju Huang State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Zhu A Wang Department of Molecular Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, California, USA PubMed articlesGoogle scholar articles
  • Dan Theodorescu Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USADepartment of Surgery (Urology), Cedars-Sinai Medical Center, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Qiang Lv Department of Urology, the First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Pengchao Li Department of Urology, the First Affiliated Hospital with Nanjing Medical University (Jiangsu Province Hospital), Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles
  • Chao Yan State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, ChinaEngineering Research Center of Protein and Peptide Medicine, Ministry of Education, Nanjing, Jiangsu, China PubMed articlesGoogle scholar articles

Citation

Zhang Y, Huo F, Cao Q, et al
FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer
Journal for ImmunoTherapy of Cancer 2022;10:e003939. doi: 10.1136/jitc-2021-003939
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.